BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16482068)

  • 21. Monoclonal antibody-based time-resolved fluorescence immunoassays for daidzein, genistein, and equol in blood and urine: application to the Isoheart intervention study.
    Talbot DC; Ogborne RM; Dadd T; Adlercreutz H; Barnard G; Bugel S; Kohen F; Marlin S; Piron J; Cassidy A; Powell J
    Clin Chem; 2007 Apr; 53(4):748-56. PubMed ID: 17317887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.
    Bloedon LT; Jeffcoat AR; Lopaczynski W; Schell MJ; Black TM; Dix KJ; Thomas BF; Albright C; Busby MG; Crowell JA; Zeisel SH
    Am J Clin Nutr; 2002 Nov; 76(5):1126-37. PubMed ID: 12399289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
    Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
    J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women.
    Zubik L; Meydani M
    Am J Clin Nutr; 2003 Jun; 77(6):1459-65. PubMed ID: 12791624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
    Vergne S; Bennetau-Pelissero C; Lamothe V; Chantre P; Potier M; Asselineau J; Perez P; Durand M; Moore N; Sauvant P
    Br J Nutr; 2008 Feb; 99(2):333-44. PubMed ID: 17678570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.
    Arai Y; Uehara M; Sato Y; Kimira M; Eboshida A; Adlercreutz H; Watanabe S
    J Epidemiol; 2000 Mar; 10(2):127-35. PubMed ID: 10778038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes.
    Setchell KD; Brown NM; Desai PB; Zimmer-Nechimias L; Wolfe B; Jakate AS; Creutzinger V; Heubi JE
    J Nutr; 2003 Apr; 133(4):1027-35. PubMed ID: 12672914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of glycosidation of isoflavones on their bioavailability and pharmacokinetics in aged male rats.
    Sepehr E; Cooke GM; Robertson P; Gilani GS
    Mol Nutr Food Res; 2009 May; 53 Suppl 1():S16-26. PubMed ID: 19437481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.
    King RA; Bursill DB
    Am J Clin Nutr; 1998 May; 67(5):867-72. PubMed ID: 9583843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
    Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
    Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a slow-release formulation of soybean isoflavones in healthy postmenopausal women.
    Setchell KD; Brzezinski A; Brown NM; Desai PB; Melhem M; Meredith T; Zimmer-Nechimias L; Wolfe B; Cohen Y; Blatt Y
    J Agric Food Chem; 2005 Mar; 53(6):1938-44. PubMed ID: 15769117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women.
    Richelle M; Pridmore-Merten S; Bodenstab S; Enslen M; Offord EA
    J Nutr; 2002 Sep; 132(9):2587-92. PubMed ID: 12221213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women.
    Piazza C; Privitera MG; Melilli B; Incognito T; Marano MR; Leggio GM; Roxas MA; Drago F
    Am J Clin Nutr; 2007 Sep; 86(3):775-80. PubMed ID: 17823445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Tworoger SS; Atkinson C; Thomas WK; Stanczyk FZ; Marcovina SM; Weigle DS; Weiss NS; Holt VL; Schwartz SM; Lampe JW
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):399-408. PubMed ID: 15145450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cholesterol efflux potential in postmenopausal women treated with isolated isoflavones.
    Törmälä RM; Nikander E; Tiitinen A; Väisänen-Tommiska M; Ylikorkala O; Mikkola TS
    Menopause; 2006; 13(1):96-101. PubMed ID: 16607104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
    van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
    Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.